Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization-Reference-Cited by-同舟云学术

Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization

Published:2017-02 Issue:3 Volume:11 Page:522-528
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Parkin Christopher G.¹,Graham Claudia²,Smolskis John³

Affiliation:

1. CGParkin Communications, Inc, Boulder City, NV, USA

2. Dexcom, Inc, San Diego, CA, USA

3. Optum, Minneapolis, MN, USA

Funder

Dexcom, Inc.

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1932296817693253

Reference30 articles.

1. American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement

2. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring

3. How Patients With Type 1 Diabetes Translate Continuous Glucose Monitoring Data into Diabetes Management Decisions

4. Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modifiable factors to prevent severe hypoglycaemic and diabetic ketoacidosis presentations in people with type 1 diabetes;Diabetic Medicine;2024-06-24

2. Current treatment options of diabetes mellitus type 1 in pediatric population;Pediatrie pro praxi;2024-06-14

3. Validation and verification framework and data integration of biosensors and in vitro diagnostic devices: a position statement of the IFCC Committee on Mobile Health and Bioengineering in Laboratory Medicine (C-MBHLM) and the IFCC Scientific Division;Clinical Chemistry and Laboratory Medicine (CCLM);2024-02-21

4. Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c;Pediatric Diabetes;2023-04-11

5. Type 1 Diabetes Continuous Glucose Monitoring Use in the Pediatric Emergency Department Affects Laboratory Test Frequency but Not Treatment Timing;Diabetes Spectrum;2023-03-15